Search
Alanine
go.drugbank.com/drugs/DB00160ApprovedInvestigationalNutraceuticalIt is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system.
Mixtures: GLAMIN SOLUTION FOR INFUSION, KABIVEN EMULSION FOR INFUSIONLeucovorin
go.drugbank.com/drugs/DB00650ApprovedInvestigationalLeucovorin, also known as folinic acid or citrovorum factor, is a reduced form of folic acid that serves as a vital coenzyme in nucleic acid synthesis. … [L56092, A257419] Unlike folic acid, leucovorin does not require the enzyme dihydrofolate reductase (DHFR) for activation, allowing it to function even when DHFR is inhibited by drugs like methotrexate
Mixtures: KOMFER FOL 40 MG/185 MCG ORAL COZELTI, 10 FLK., KOMFER FOL 40 MG/185 MCG ORAL COZELTI, 20 FLK.Categories: Detoxifying Agents for Antineoplastic Treatment, Compounds used in a research, industrial, or household settingMeningioma of Brain
go.drugbank.com/conditions/DBCOND0169076Drugs: HydroxyureaSynonyms: Meningioma, benign, no International Classification of Diseases for Oncology subtypeCoagulation factor X human
go.drugbank.com/drugs/DB13148ApprovedInvestigationalCoagulation Factor X is a vitamin K-dependent, liver-produced serine protease that serves as the first enzyme in the coagulation cascade to form fibrin. … Coagulation Factor X (Human) solution is approved by the FDA for intravenous injection under the market name Coagadex which contains normally 100 IU/mL of coagulation Factor X derived from healthy donors
Mixtures: OCTAPLEX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU, BERIPLEX P/N 500 POWDER FOR SOLUTION FOR INJECTIONMetamizole
go.drugbank.com/drugs/DB04817ApprovedInvestigationalWithdrawn[L42975] In 1963, metamizole was withdrawn from the Canadian market and banned in the UK, France, Sweden, Norway and Australia. … Approvals of the NDA's for metamizole drug products were withdrawn on June 27, 1977 (see the Federal Register of June 17, 1977, 42 FR 30893).
Products: DIPIRONA 1 GAMPOLLA POR 2 MLThrombin
go.drugbank.com/drugs/DB11300ApprovedInvestigationalOnce converted from prothrombin, thrombin converts fibrinogen to fibrin, which, in combination with platelets from the blood, forms a clot. … Bleeding may result from the development of antibodies against bovine factor V [FDA Label].
Mixtures: Artiss Solutions for Sealant, Deep Frozen, ARTISS - Lösungen für einen GewebekleberIndocyanine green acid form Drug Metabolism
smpdb.ca/view/SMP0130870MetabolicIndocyanine green acid form passes through the liver and is then excreted from the body mainly through the kidney. … Indocyanine green acid form is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Indocyanine green acid formTerbinafine
go.drugbank.com/drugs/DB00857ApprovedInvestigationalVet approved[A1279] Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (also called squalene epoxidase), an enzyme that is part of the fungal cell wall
Categories: Antifungals for Topical Use, Antifungals for Systemic UseProducts: Lamisil AT for Jock Itch, K-MICOT ® 250 MG TABLETASMinnelide
go.drugbank.com/drugs/DB17309InvestigationalSynonyms: 14-o-phosphonooxymethyltriptolide disodium salt, Trisoxireno(4b,5:6,7:8a,9)phenanthro(1,2-c)furan-1(3h)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-8b-methyl-6a-(1-methylethyl)-6-((phosphonooxy)methoxy)-, sodium salt (1:2), (3bs,4as,5ar,6r,6as,7as,7bs,Cerliponase alfa
go.drugbank.com/drugs/DB13173ApprovedInvestigational[L51319] On April 27, 2017, cerliponase alfa was first approved by the FDA as the first treatment for neuronal ceroid lipofuscinosis type 2 (CLN2), also known as TPP1 deficiency. … [L51339] It was also approved by the EMA on May 30, 2017 [L51324] and by Health Canada on December 19, 2018.